Advantages of Early Minimally Invasive Surgery for Intracerebral Hemorrhage
Abstract: Recent trials examining the efficacy of surgical evacuation for supratentorial intracerebral hemorrhages have predominantly indicated [...]
Ionis Pharma Advances Olezarsen Towards Launch for Rare Disease Treatment Following Promising Trial Results
Ionis Pharma announced its progress with olezarsen, an investigational compound for treating familial chylomicronemia syndrome (FCS), [...]
Study Links GLP-1 Diabetes and Obesity Drugs to Increased Risk of Aspiration Pneumonia Post-Endoscopy
A recent study highlighted in the journal Gastroenterology has unveiled potential concerns associated with GLP-1 diabetes [...]
Breakthrough Study Identifies Three Subtypes of Multiple Sclerosis Based on Immune Markers
A groundbreaking study conducted in Germany has unveiled three distinct subtypes of Multiple Sclerosis (MS), categorized [...]
Podcast Q&A: Clinical Outcomes Assessments and Training
In this episode of tHEORetically Speaking, join Kelly Lipman, Heather Dickerson, and Ryan Murphy from ICON, who answer questions from a recent webinar on the dynamic landscape of clinical outcomes assessments, examining their historical significance, current uses and best practices, and making a case for greater standardization in their implementation.
Podcast Q&A: Cell & Gene Therapies
In this episode of tHEORetically Speaking, join Dr. Pamela Landsman-Blumberg, Amanda O’Hora, and Ajay Keshava from Magnolia Market Access, who answer questions from a recent webinar on how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
Podcast Q&A: Patient-Centered Real-World Evidence in Rare Diseases
In this episode of tHEORetically Speaking, join Drs. Megan Gower and Edward Chou from Takeda, and Richard Tsai, MS from Inspire, who answer questions from a recent webinar on the challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases, to support clinical development through commercial post-approval.
GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients
A cross-sectional study involving 124 fasted patients undergoing elective procedures under anesthesia revealed that users of [...]
Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues
Researchers in the U.K. have made a significant discovery in fetal health research by identifying viable [...]
Gilead Sciences Faces Setbacks with Magrolimab in Solid Tumor Trials
Gilead Sciences has encountered significant challenges with its anti-CD47 monoclonal antibody, magrolimab, leading to a pause [...]
Biden Administration Boosts Long Covid Research Funding by $515 Million
The Biden administration has announced a substantial increase in funding for long Covid research, adding $515 [...]
Study Reveals Long-Term Immune System Damage from Smoking
Recent research published in Nature has shed new light on the long-lasting adverse effects of smoking [...]
Study Reveals Ebola Vaccine’s Potential to Save Lives Even After Infection
A recent study has provided significant insights into the efficacy of the Ebola vaccine, particularly in [...]
Study Challenges Efficacy of High-Dose Naloxone in Opioid Overdose Survival, Raises Concerns Over Cost and Withdrawal Symptoms
A study published in the CDC's Morbidity and Mortality Weekly Report found no significant survival advantage [...]
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
In this webinar, panelists address integrating patient-centered research into real-world studies, focusing on diversity, equity, and inclusion (DEI), and developing systemic approaches for a more equitable research ecosystem.
CDC Study Finds Latest Covid-19 Booster 54% Effective Against Infection
The CDC reported that the latest COVID-19 booster is about 54% effective against infection, including the [...]
Link Discovered Between Cadaveric Hormone Treatment and Early-Onset Alzheimer’s
In a striking discovery reported in Nature Medicine, a group of patients who received cadaver-derived growth [...]
Pfizer’s Muted Enthusiasm for Abrysvo Amid Stiff Competition and Strategic Shifts
At the J.P. Morgan Healthcare Conference, Pfizer's CEO Albert Bourla labeled the launch of the RSV [...]
Invasive Breast Cancer and Mortality Risks after Non-Screen Detected Ductal Carcinoma In Situ: A 28-Year Cohort Study in England
This study, published in BMJ in 2024, investigates the long-term risks of invasive breast cancer and [...]
Chronic Covid in Immunocompromised Patients: Risks and Implications for Viral Evolution
Recent research in "Science Translational Medicine" sheds light on chronic COVID-19, a condition where the virus [...]
Ionis Pharmaceuticals’ Donidalorsen Shows Promise in Treating Rare Swelling Disease, Hereditary Angioedema
Ionis Pharmaceuticals reported that its drug, Donidalorsen, significantly reduced attacks in patients with hereditary angioedema, a [...]
Lutathera’s Promise: A Potential $1 Billion First-Line Treatment Market
Novartis's drug Lutathera showed promise in a phase 3 trial for treating certain advanced gastroenteropancreatic neuroendocrine [...]
Revolutionizing IVF: UC San Diego Researchers Develop Non-Invasive Embryo Quality Prediction Method
Researchers at UC San Diego School of Medicine have developed a new method to improve the [...]
Revolutionizing Cancer Care: Integration of Genomic and Clinical Data in Precision Oncology
This study, published in Nature Medicine and led by institutions like Genomics England, NHS England, and [...]
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Watch this webinar on addressing early onset cancer through strategic trial design, targeted launch indications, and increased trial access to speed up the delivery of impactful treatments.
